PO-1159 Prognostic role of pro-inflammatory cytokines in multimodal treatment of inoperable stage III NSCLC. (August 2021) - Käsmann, L.; Cabeza-Boeddinghaus, N.; Taugner, J.; Eze, C.; Flörsch, B.; Hofer, T.; Pelikan, C.; Belka, C.; Noessner, E.; Staab-Weijnitz, C.; Manapov, F.